Q2 2026 Results
Proto Labs Inc. (NYSE: PRLB) announced second‑quarter 2026 revenue of $149.3 million, a 10.6% year‑over‑year increase from $135.1 million in Q2 2025, surpassing analysts' estimate of $143.85 million. Adjusted earnings per share were $0.60, beating the consensus forecast of $0.47 by $0.13. The company’s gross margin expanded by 200 basis points to 46.8%, while adjusted operating margin rose 340 basis points to 12.0%.
Guidance Update
Proto Labs raised its full‑year 2026 revenue growth outlook to a range of 8%–10%, up from the prior 6%–8% guidance. For the third quarter of 2026, the company projects revenue between $145.0 million and $153.0 million, with a midpoint of $149.0 million, slightly above the analyst consensus of $145.6 million. Adjusted EPS for Q3 is guided to $0.56‑$0.64, with a midpoint of $0.60, exceeding the consensus estimate of $0.51.
Segment Performance
CNC machining revenue grew 13.6% year‑over‑year to $70.4 million, while injection molding revenue increased 13.1% to $53.6 million. Both segments contributed to the overall margin expansion.
Market Reaction
Following the earnings release, Proto Labs’ shares rose 2.48% in pre‑market trading, reflecting investor approval of the earnings beat and the upgraded outlook.
Management Commentary
President and CEO Suresh Krishna stated, "We delivered another strong quarter with record revenue, double‑digit revenue growth, and both gross and operating margin expansion. More importantly, we are seeing increasing evidence that our strategy is gaining traction across the business, with larger strategic customers expanding their relationships with Protolabs."